Your browser doesn't support javascript.
loading
Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice.
Ragusa, Simone; Prat-Luri, Borja; González-Loyola, Alejandra; Nassiri, Sina; Squadrito, Mario Leonardo; Guichard, Alan; Cavin, Sabrina; Gjorevski, Nikolce; Barras, David; Marra, Giancarlo; Lutolf, Matthias P; Perentes, Jean; Corse, Emily; Bianchi, Roberta; Wetterwald, Laureline; Kim, Jaeryung; Oliver, Guillermo; Delorenzi, Mauro; De Palma, Michele; Petrova, Tatiana V.
Afiliação
  • Ragusa S; Department of Oncology, University of Lausanne and CHUV, Epalinges, Switzerland.
  • Prat-Luri B; Ludwig Institute for Cancer Research Lausanne, Epalinges, Switzerland.
  • González-Loyola A; Department of Oncology, University of Lausanne and CHUV, Epalinges, Switzerland.
  • Nassiri S; Ludwig Institute for Cancer Research Lausanne, Epalinges, Switzerland.
  • Squadrito ML; Department of Oncology, University of Lausanne and CHUV, Epalinges, Switzerland.
  • Guichard A; Ludwig Institute for Cancer Research Lausanne, Epalinges, Switzerland.
  • Cavin S; Bioinformatics Core Facility, Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Gjorevski N; Swiss Institute for Experimental Cancer Research, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland.
  • Barras D; Swiss Institute for Experimental Cancer Research, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland.
  • Marra G; Swiss Institute for Experimental Cancer Research, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland.
  • Lutolf MP; Division of Thoracic Surgery, CHUV, Lausanne, Switzerland.
  • Perentes J; Institute of Bioengineering, School of Life Sciences, EPFL, Lausanne, Switzerland.
  • Corse E; Bioinformatics Core Facility, Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Bianchi R; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • Wetterwald L; Institute of Bioengineering, School of Life Sciences, EPFL, Lausanne, Switzerland.
  • Kim J; Division of Thoracic Surgery, CHUV, Lausanne, Switzerland.
  • Oliver G; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, (pRED), Schlieren, Switzerland.
  • Delorenzi M; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, (pRED), Schlieren, Switzerland.
  • De Palma M; Department of Oncology, University of Lausanne and CHUV, Epalinges, Switzerland.
  • Petrova TV; Ludwig Institute for Cancer Research Lausanne, Epalinges, Switzerland.
J Clin Invest ; 130(3): 1199-1216, 2020 03 02.
Article em En | MEDLINE | ID: mdl-32015230
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Resistencia a Medicamentos Antineoplásicos / Inibidores da Angiogênese / Antineoplásicos Imunológicos / Imunoterapia / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Resistencia a Medicamentos Antineoplásicos / Inibidores da Angiogênese / Antineoplásicos Imunológicos / Imunoterapia / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça